News & Updates

GLP-1RAs lower depression risk in older adults with T2D

03 Mar 2025

The incidence of depression among older adults with type 2 diabetes is low, and the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) helps reduce the risk of depression relative to dipeptidyl peptidase-4 inhibitors (DPP4is), but not sodium–glucose cotransporter-2 inhibitors (SGLT2is).

GLP-1RAs lower depression risk in older adults with T2D

03 Mar 2025

Can semaglutide curb drinking?

02 Mar 2025 by

The glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide has the potential to reduce alcohol cravings and consumption in adults with alcohol use disorder (AUD), as shown in a phase II study.

Can semaglutide curb drinking?

02 Mar 2025

Machine learning model for predicting progression to schizophrenia feasible

28 Feb 2025

Analysis of routine clinical data via machine learning show promise for predicting the progression to schizophrenia within 5 years among patients with pre-existing mental illness, as shown in a study.

Machine learning model for predicting progression to schizophrenia feasible

28 Feb 2025

PCOS linked to unfavourable eating patterns among middle-aged women

25 Feb 2025

Women with polycystic ovarian syndrome (PCOS) in their middle years are prone to exhibiting unfavourable eating behaviours, according to a study.

PCOS linked to unfavourable eating patterns among middle-aged women

25 Feb 2025

Cognitive behavioural therapy: Online just as good as in-person delivery

21 Feb 2025

A retrospective cohort study has shown that short first-line treatments with therapist-guided, internet-delivered cognitive behavioural therapy (CBT) yield comparable outcomes as face-to-face CBT.